msi h dmmr - Robuta Search

https://oncodaily.com/new-paper-alert/keynote-158-pembrolizumab-gliomas KEYNOTE-158: Pembrolizumab in MSI-H/dMMR Gliomas Apr 6, 2026 - KEYNOTE-158 shows pembrolizumab has limited but durable activity in MSI-H/dMMR recurrent gliomas, with manageable safety. msi h dmmr keynote 158 pembrolizumab gliomas https://www.keytruda.com/msi-h-dmmr-colorectal-cancer/ Advanced MSI-H/dMMR Colorectal Cancer (CRC) Learn about immunotherapy treatment options for advanced MSI-H/dMMR colorectal cancer (CRC). Review clinical trial data for KEYTRUDA® (pembrolizumab) and... msi h dmmr colorectal cancer advanced crc https://www.oncologyeducation.com/videos/management-of-msi-h-dmmr-metastatic-colorectal-cancer/ Management of MSI-H/dMMR Metastatic Colorectal Cancer - OncologyEducation Dec 3, 2025 - test Studies/trials discussed: Abstract #3501 – Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) or NIVO monotherapy for microsatellite... msi h dmmr metastatic colorectal cancer management oncologyeducation